Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma
Clinical trial NCT04126993 · UNKNOWN
Trial details
- NCT number
- NCT04126993
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2019-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.